ABSTRACT
Fact Sheet for Healthcare Providers: Genalyte, Inc., Maverick SARS-CoV-2 Multi-Antigen Serology Panel v2 [open pdf - 150KB]
From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the Maverick SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] Multi-Antigen Serology Panel v2. [...] This test detects human SARS-CoV-2 antibodies that are generated as part of the human adaptive immune response to the COVID-19 [coronavirus disease 2019] virus and is to be performed on only human dipotassium EDTA [ethylenediaminetetraacetic acid] venous whole blood, dipotassium EDTA plasma and serum specimens."
| Publisher: | |
| Date: | 2020-10-08 |
| Series: | |
| Copyright: | Public Domain |
| Retrieved From: | U.S. Food and Drug Administration: https://www.fda.gov/ |
| Format: | pdf |
| Media Type: | application/pdf |
| URL: |